drugs

See the following -

NY Attorney General Confirms Real-Life Conspiracy Among Drug Companies

J.D. Heyes | Natural News | February 21, 2014

The office of the New York Attorney General and the American units of Ranbaxy Laboratories Ltd. and Teva Pharmaceutical Industries Ltd. have come to terms on a settlement involving claims that an agreement between the two Big Pharma companies restricted competition unlawfully. Read More »

Open Data Probe Shows NHS Statin Bill Twice What It Should Be

Staff Writer | British Journal of Healthcare Computing | July 12, 2012

A start up using some of the flood of new government data being published says the NHS could make considerable savings on its drug expenditure if it wanted. Does it have a point? Read More »

Open Source Effort Develops Affordable Drugs

Press Release | Stevens Institute of Technology | March 14, 2013

In order to accelerate the development of new drugs to combat and cure major infectious diseases, Professor A.K. Ganguly of the Department of Chemistry, Chemical Biology & Biomedical Engineering at Stevens Institute of Technology is contributing his expertise and passion to the Council of Scientific and Industrial Research (CSIR) Open Source Drug Discovery initiative. Read More »

Oscars Of Science: Breakthrough Awards Hands Out $21m To Transform Physicists Into Rockstars

Tim Walker | The Independent | December 13, 2013

In Hollywood this week, the talk was all about the Golden Globe nominations, but several hundred miles to the north, Silicon Valley’s biggest names were enjoying a new kind of awards ceremony – and they invited one of the film industry’s favourite sons to host it. Read More »

PLOS & DNDi Launch A New Collection Celebrating A Decade Of Open Access And NTD R&D

Rhona MacDonald | PLOS.org | December 5, 2013

As part of a collaborative initiative, PLOS and the Drugs for Neglected Diseases initiative (DNDi) are delighted to launch a special Collection—PLOS & DNDi: a decade of Open Access and Neglected Tropical Diseases R&D—to coincide with a joint event at the Institut Pasteur in Paris celebrating the 10 year anniversary of DNDi... Read More »

Prescribable Mobile Apps Huge Threat For Pharma

Dave Chase | Forbes | May 14, 2012

With the proliferation of mHealth apps, it was only a matter of time before healthcare providers would start prescribing apps as soon as apps proved to be as or more effective than prescription drugs. Read More »

Prescribe Cheaper Drugs, British Doctors Told

Oliver Wright | The Independent | December 31, 2012

Doctors who unnecessarily prescribe expensive branded drugs to patients when cheaper alternatives are available are facing a crackdown as [Britain's] NHS attempts to reduce its annual £8bn family medicine bill. Read More »

Revolutionary New Antibiotic Alternative Could Save The World From Superbug 'Apocalypse'

Amelia Smith | Newsweek | November 6, 2014

Scientists have developed a new alternative to antibiotics that could revolutionise the way we treat superbugs and avoid a scenario where common medical procedures become life-threatening due to bacteria becoming immune to conventional drugs...

Read More »

SA’s Open-Source ‘Metabolic Chamber’

Staff Writer | TechCentral | December 5, 2012

A Stellenbosch-based start-up wants to debunk health myths and offer researchers, and anyone else who’s interested, access to the data from its custom-built “metabolic chamber”. Read More »

Stevens Professor Joins Open Source Effort To Develop Low-Cost Drugs

Press Release | Stevens Institute of Technology | March 16, 2013

Professor A.K. Ganguly of the Department of Chemistry, Chemical Biology & Biomedical Engineering at Stevens Institute of Technology is contributing his expertise and passion to the Council of Scientific and Industrial Research (CSIR) Open Source Drug Discovery initiative... Read More »

Study: Brand Name Drugs Drive Up Medicare Spending

Ankita Rao | The Washington Post | June 11, 2013

A new study suggests that cash-strapped Medicare missed an opportunity to save more than $1 billion by not addressing the varying costs and use of prescription drugs. Read More »

Substance-Use Disorders Linked To Increased Risk Of Death For Veterans With PTSD

Press Release | University of Michigan Health System | September 18, 2012

Veterans suffering from post-traumatic stress disorder who are also battling drug or alcohol problems face a higher risk of death, according to new research from the University of Michigan Health System and the VA Ann Arbor Healthcare System.

Read More »

Tamiflu Cost Us £424m Yet We Still Don’t Know Much About It

Tom Jefferson | The Conversation | June 3, 2013

Are you worried about how decisions involving public money are made? You should be. Read More »

TB or Not TB: India Crowdsources Research

Jason Overdorf | GlobalPost | July 11, 2012

Facing nearly 2 million new tuberculosis cases every year — more and more of them drug-resistant — India has a bigger stake in finding a better treatment for TB than any other country. Read More »

The Case For Open Access

Bart GJ Knols | Xindex | August 30, 2012

For most of us, it’s entirely logical that medical practitioners should be familiar with the latest scientific knowledge and evidence-based practices in order to treat ailments. This forms our fundamental basis of trust in medical professionals...But what if you live in sub-Saharan Africa, where the vast majority of medical personnel, as well as scientists, researchers and medical students, remain badly deprived of the latest medical developments? Read More »